NCCN 2012 Webinar Series: Sarcomas™: Advanced, Metastatic, and Progressive Soft Tissue Sarcomas: Current and Future Treatment Options

December 10, 2012

This webinar series is designed to provide an in-depth analysis of the evidence and clinical decision-making that led to the development of the NCCN Guidelines® for Sarcomas (Soft Tissue and Bone). Participants will learn how to implement the NCCN Guidelines recommendations into their practice and gain a clear understanding of the most up-to-date treatment recommendations for these cancers. As research continues in these areas and new information emerges, it is critical that clinicians are kept up-to-date and informed. These webinars will communicate the NCCN Guidelines in a direct and interactive way to community oncologists and other clinical professionals.

Target Audience

This educational program is designed to meet the educational needs of oncologists, pathologists, nurses, pharmacists, and other health care professionals who manage patients with cancer.

Learning Objectives

Following this webinar, participants should be able to:

  • Discuss the standard treatment approaches for patients with advanced or metastatic STS
  • Describe the limitations of the treatment and the need for the development of more effective treatment options
  • Review the clinical evidence from ongoing trials evaluating novel treatment options and the potential role of new agents in the treatment algorithm
  • Interpret the data on the safety and efficacy of novel targeted therapies for the treatment of various histologic subtypes of STS
Additional information
Supporters: 

This activity is supported by educational grants from Bayer HealthCare Pharmaceuticals Inc, Novartis Pharmaceuticals Corporation, and ZIOPHARM Oncology, Inc.

Course summary
Available credit: 
  • 1.00 Participation
  • 1.00 Nurse
  • 1.00 Pharmacist
  • 1.00 Physician
Course opens: 
12/10/2012
Course expires: 
02/28/2013
Event starts: 
12/10/2012 - 12:00pm
Event ends: 
12/10/2012 - 1:00pm
Cost:
$0.00

Richard F. Riedel, MD
Duke Cancer Institute

Available Credit

  • 1.00 Participation
  • 1.00 Nurse
  • 1.00 Pharmacist
  • 1.00 Physician

Accreditation Period

Course opens: 
12/10/2012
Course expires: 
02/28/2013

Price

Cost:
$0.00
Please login or register to take this course.